Black Rock Inc. Travere Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,644,789 shares of TVTX stock, worth $131 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,644,789

Previous 7,796,766 1.95%

Holding current value

$131 Million

Previous $60.1 Million 4.54%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.26 - $8.28 $799,399 - $1.26 Million	-151,977 Reduced 1.95%	7,644,789 $62.8 Million
Q1 2024 May 10, 2024	SELL	$7.18 - $9.82 $869,454 - $1.19 Million	-121,094 Reduced 1.53%	7,796,766 $60.1 Million
Q4 2023 Feb 13, 2024	BUY	$5.44 - $9.5 $1.55 Million - $2.7 Million	284,655 Added 3.73%	7,917,860 $71.2 Million
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $3.94 Million - $8.91 Million	516,287 Added 7.25%	7,633,205 $68.2 Million
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $16.4 Million - $24.2 Million	1,069,002 Added 17.68%	7,116,918 $109 Million
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $17 Million - $21.8 Million	953,528 Added 18.72%	6,047,916 $136 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $9.78 Million - $13.8 Million	529,638 Added 11.6%	5,094,388 $107 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $1.42 Million - $1.78 Million	62,173 Added 1.38%	4,564,750 $112 Million
Q2 2022 Aug 12, 2022	BUY	$20.94 - $30.01 $361,822 - $518,542	17,279 Added 0.39%	4,502,577 $109 Million
Q1 2022 May 12, 2022	SELL	$23.61 - $30.6 $704,687 - $913,318	-29,847 Reduced 0.66%	4,485,298 $116 Million
Q4 2021 Feb 10, 2022	SELL	$24.34 - $31.17 $1.16 Million - $1.49 Million	-47,705 Reduced 1.05%	4,515,145 $140 Million
Q3 2021 Nov 09, 2021	SELL	$12.98 - $25.03 $5.58 Million - $10.8 Million	-429,675 Reduced 8.61%	4,562,850 $111 Million
Q2 2021 Aug 11, 2021	BUY	$14.11 - $26.4 $70.4 Million - $132 Million	4,992,525 New	4,992,525 $72.8 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.1B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account